Literature DB >> 8288784

Malignant cutaneous tumors in children. Twenty years of experience at a large pediatric hospital.

M de la Luz Orozco-Covarrubias1, L Tamayo-Sanchez, C Duran-McKinster, C Ridaura, R Ruiz-Maldonado.   

Abstract

The frequency of different malignant cutaneous tumors (MCTs), primary and metastatic, in children is not known. We reviewed all MCTs, primary and metastatic, seen during a 20-year period in a large general pediatric hospital. Fifty-three MCTs, 36 primary and 17 metastatic, were diagnosed in 36,207 pediatric dermatology patients. The incidence was 1.4 per 1000 patients. The relative frequency of occurrence of the different tumors was as follows: rhabdomyosarcoma, 25%; lymphomas, 19%; basal cell carcinoma, 13%; leukemia, 13%; neuroblastoma, 10%; malignant melanoma, 6%; squamous cell carcinoma, 6%; unclassified sarcomas, 4%; epithelioid schwannoma, 2%; ependymoma, 2%. The mean follow-up was 3 years; 48% died, 27% were lost to follow-up, and 25% are under control. We conclude that primary and metastatic MCTs in children are rare. Their types differ from MCTs in an older age population. MCTs in children are associated with a high mortality rate, often related to late recognition.

Entities:  

Mesh:

Year:  1994        PMID: 8288784

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence.

Authors:  Adèle C Green; Sarah C Wallingford; Penelope McBride
Journal:  Prog Biophys Mol Biol       Date:  2011-09-03       Impact factor: 3.667

2.  Basal cell carcinoma in a child.

Authors:  Samet Vasfi Kuvat; Zuhal Gücin; Barış Keklik; Gülzade Ozyalvaçlı; Karaca Başaran
Journal:  J Skin Cancer       Date:  2010-09-22

3.  Malignant transformation of nevus sebaceous to basal-cell carcinoma: Case series, literature review, and management algorithm.

Authors:  Yeon Ji Lee; Hye Ju Han; Dong Yeon Kim; Chang Young Yoo; Jin Soo Lim
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.